智慧药丸市场规模、份额、成长分析（按目标领域、应用、适应症、最终用户和地区）- 2025 年至 2032 年产业预测

2023 年智慧药丸市场规模价值 10 亿美元，预计将从 2024 年的 11.1 亿美元成长到 2032 年的 26.2 亿美元，预测期间（2025-2032 年）的复合年增长率为 11.3%。

智慧药丸市场正在经历显着成长，这得益于心臟病、糖尿病和呼吸系统疾病等需要严格遵守药物治疗的慢性疾病的盛行率不断上升。面对因违规导致的患者健康状况下降和医疗成本上升，将数位科技融入药物管理变得至关重要。智慧药丸配备感测器、微晶片和无线通讯，可增强患者追踪，并实现患者和医疗保健专业人员之间的即时数据共用。此外，优惠的支付模式、对微创手术的日益增长的偏好以及内视镜技术的进步都在支持市场的发展。人工智慧与智慧药丸技术的协同效应将进一步增强数据分析，提高早期诊断、治疗准确性和预防性医疗保健策略。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 专利分析
• 技术分析
• 案例研究
• 客户和购买标准分析

智慧药丸市场规模（依目标区域划分）及复合年增长率（2025-2032）

• 市场概览
• 小肠
• 冒号
• 食道
• 胃

智慧药丸市场规模（按应用）及复合年增长率（2025-2032）

• 市场概览
• 胶囊内视镜
• 病患监测
• 靶向药物输送

智慧药丸市场规模（按适应症和复合年增长率） (2025-2032)

• 市场概览
• 隐匿性胃肠道出血
• 克隆氏症
• 小肠肿瘤
• 乳糜泻
• 其他适应症

智慧药丸市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 诊断中心
• 门诊部（诊所、门诊治疗中心）
• 其他最终用户

智慧药丸市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic PLC（Ireland）
• Proteus Digital Health Inc.（US）
• CapsoVision Inc.（US）
• Olympus Corporation（Japan）
• Medisafe（US）
• Bio-Images Research Limited（UK）
• BodyCap（France）
• Philips Healthcare（Netherlands）
• Medimetrics Personalized Drug Delivery BV（Netherlands）
• PENTAX Medical（Japan）
• Proteus Biomedical（US）
• Check-Cap Ltd.（Israel）
• IntroMedic Co. Ltd.（South Korea）

结论和建议

Smart Pills Market size was valued at USD 1.0 billion in 2023 and is poised to grow from USD 1.11 billion in 2024 to USD 2.62 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).

The smart pills market is experiencing significant growth, driven by the rising prevalence of chronic diseases like heart disease, diabetes, and respiratory issues, which necessitate stringent medication adherence. With patients facing poor health outcomes and increased healthcare costs due to non-compliance, the integration of digital technology in medication management has become essential. Smart pills, equipped with sensors, microchips, and wireless communication, enhance patient-tracking capabilities, allowing real-time data sharing between patients and healthcare professionals. Additionally, the market is supported by favorable payment models, a growing preference for minimally invasive procedures, and technological advancements in endoscopy. The synergy of artificial intelligence with smart pill technology is further enhancing data analytics, thus improving early diagnosis, treatment precision, and preventive care strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Smart Pills market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Smart Pills Market Segments Analysis

Global Smart Pills Market is segmented by Target Area, Application, Disease Indication, End User and region. Based on Target Area, the market is segmented into Small Intestine, Large Intestine, Esophagus and Stomach. Based on Application, the market is segmented into Capsule Endoscopy, Patient Monitoring and Targeted Drug Delivery. Based on Disease Indication, the market is segmented into Occult Gi Bleeding, Crohn's Disease, Small Bowel Tumors, Celiac Disease and Other Disease Indications. Based on End User, the market is segmented into Hospitals, Diagnostic Centers, Outpatient Settings (Clinics, Ambulatory Care Centers) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Smart Pills Market

The integration of digital technologies in healthcare significantly drives the smart pills market. As the demand for patient-centered care and real-time health monitoring increases, smart medications emerge as innovative solutions that merge medication adherence with effective data tracking. These advanced medicines provide valuable degradation information, such as pH levels, temperature, and various physiological parameters, which can be transmitted directly to healthcare providers. This capability enables physicians to monitor patients more closely, enhance compliance, and minimize the risk of medication errors. The growing trend of personalized precision medicine is encouraging healthcare providers and clinicians to invest in and embrace smart pharmaceutical solutions, aligning with the overall shift toward digital health initiatives.

Restraints in the Smart Pills Market

Despite the numerous advantages offered by smart pills, their high price remains a significant obstacle to broader acceptance. The production of these advanced devices necessitates complex technology, including sensors, microchips, and wireless transmitters, which drive up manufacturing expenses. As a result, smart pills can become prohibitively expensive, particularly in low- and middle-income regions where healthcare resources are limited. Additionally, the absence of well-defined reimbursement frameworks for digital health innovations, such as smart pills, poses further difficulties for healthcare providers and insurance companies, hindering the integration of this innovative technology into mainstream healthcare solutions.

Market Trends of the Smart Pills Market

The Smart Pills market is witnessing a significant trend driven by advances in micro-sensor technology, enhancing the efficiency and capabilities of smart drugs. These modern tablets are equipped with miniature sensors that meticulously track vital gastrointestinal data, such as motility, acid levels, and real-time drug absorption metrics. This transformation positions smart pills as autonomous tools crucial for personalizing treatment and promoting behavioral development in patients. As healthcare trends lean toward more integrated and data-driven solutions, the demand for these innovative smart pills is expected to surge, offering immense potential for improved patient outcomes and streamlined healthcare delivery systems.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Technology Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Smart Pills Market Size by Target Area & CAGR (2025-2032)

• Market Overview
• Small Intestine
• Large Intestine
• Esophagus
• Stomach

Global Smart Pills Market Size by Application & CAGR (2025-2032)

• Market Overview
• Capsule Endoscopy
• Patient Monitoring
• Targeted Drug Delivery

Global Smart Pills Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Occult Gi Bleeding
• Crohn's Disease
• Small Bowel Tumors
• Celiac Disease
• Other Disease Indications

Global Smart Pills Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Outpatient Settings (Clinics, Ambulatory Care Centers)
• Other End Users

Global Smart Pills Market Size & CAGR (2025-2032)

• North America (Target Area, Application, Disease Indication, End User)
  • US
  • Canada
• Europe (Target Area, Application, Disease Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Target Area, Application, Disease Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Target Area, Application, Disease Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Target Area, Application, Disease Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteus Digital Health Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CapsoVision Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Images Research Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BodyCap (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medimetrics Personalized Drug Delivery B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PENTAX Medical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteus Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Check-Cap Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IntroMedic Co. Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations